C
CARTESIAN THERAPEUTICS INC.
NASDAQ: RNAC (Cartesian Therapeutics, Inc.)
Kemas kini terakhir: 20 jam lalu6.49
-0.26 (-3.85%)
| Penutupan Terdahulu | 6.75 |
| Jumlah Dagangan | 78,798 |
| Harga / Jualan (P/S) | 123.73 |
| Julat 52 Minggu |
| Margin Keuntungan | -112.11% |
| Margin Operasi (TTM) | -1,989.91% |
| EPS Cair (TTM) | 5.33 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -81.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1,948.27% |
| Nisbah Semasa (MRQ) | 12.34 |
| Aliran Tunai Operasi (OCF TTM) | -30.86 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -47.63 M |
| Pulangan Atas Aset (ROA TTM) | -7.55% |
| Pulangan Atas Ekuiti (ROE TTM) | -7,029.26% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Cartesian Therapeutics, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -4.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -2.5 |
| Persekitaran Makro | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -0.27 |
|
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 59.96% |
| % Dimiliki oleh Institusi | 25.63% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Privium Fund Management B.V. | 30 Jun 2026 | 151,675 |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |